Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Cytomx Therapeutics Inc | 1 | 1 | 1 | 1 | €1.69 | €50.00 | 2858.580% |
| Applied Therapeutics Inc | 1 | 1 | 0 | 0 | €3.88 | €4.00 | 3.040% |
| Carbylan Therapeutics Inc | 1 | 1 | 0 | 0 | €10.90 | €22.00 | 101.835% |
| B.R.A.I.N. Biotechnology Research and Information Network AG | 1 | 1 | 0 | 0 | €2.76 | €30.00 | 986.957% |
| Agenus Inc. | 3 | 2 | 1 | 0 | €0.41 | €22.25 | 5276.897% |
| Gritstone Oncology Inc | 3 | 2 | 1 | 0 | €0.76 | €6.43 | 741.007% |
| Roche Holding AG ADR | 2 | 1 | 0 | 0 | €30.08 | €38.00 | 26.333% |
| Carl Zeiss Meditec AG | 2 | 1 | 0 | 0 | €93.85 | €101.00 | 7.619% |
| Fate Therapeutics Inc. | 4 | 3 | 1 | 1 | €3.40 | €8.27 | 143.482% |
| Formycon AG | 3 | 1 | 0 | 0 | €43.05 | €100.00 | 132.288% |
| Palisade Bio Inc. | 3 | 1 | 1 | 0 | €0.34 | €21.06 | 6072.333% |
| Inotiv Inc. | 3 | 1 | 1 | 0 | €1.97 | €10.66 | 441.203% |
| Evotec SE | 3 | 1 | 0 | 0 | €9.38 | €21.50 | 129.211% |
| Sage Therapeutics Inc. | 5 | 3 | 1 | 0 | €11.04 | €26.71 | 141.982% |
| Orasure Tech | 3 | 1 | 0 | 0 | €4.50 | €8.36 | 85.740% |
| Pacific Biosciences of California Inc. | 10 | 5 | 0 | 0 | €1.70 | €10.20 | 499.571% |
| Ocuphire Pharma Inc. | 6 | 1 | 1 | 0 | €1.55 | €18.37 | 1084.903% |
| QuidelOrtho Corp. | 7 | 2 | 1 | 0 | €38.20 | €73.22 | 91.672% |
| Ironwood Pharmaceuticals | 8 | 1 | 1 | 0 | €5.95 | €18.80 | 215.918% |
| Bristol-Myers Squibb | 11 | 3 | 1 | 0 | €39.22 | €67.64 | 72.483% |
| Alkermes plc | 12 | 2 | 0 | 0 | €22.20 | €34.08 | 53.517% |
| Teladoc Health Inc | 11 | 1 | 3 | 0 | €10.87 | €23.12 | 112.728% |
| Ionis Pharmaceuticals Inc. | 19 | 5 | 2 | 0 | €34.30 | €56.86 | 65.778% |
| Illumina Inc. | 19 | 4 | 2 | 0 | €99.26 | €169.78 | 71.043% |
| Acadia Pharmaceuticals | 28 | 1 | 6 | 0 | €13.74 | €31.78 | 131.325% |